Tapewire

Nasdaq · USD

NVCR

NovoCure Ltd

Export transactions ↓
Tapewire entity
4494
SEC CIK
0001645113
Parsed reports
725

Last 12 months

Inside the activity.

0 purchase rows · 25 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202605
Mar 2026012
Apr 202600
May 202600
Jun 202608
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 01, 2017 Filed May 3, 2017 16:05 UTC
Palti YoramDirector · Chief Technology Officer
SaleOrdinary Shares 4,000 $11.44 $45,776.00
Disclosure

SEC source: 0000899243-17-011613 · doc4.xml · nonDerivative · entry 1

Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,825

F1 · price: On May 1, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $11.20 to $11.80. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 28, 2017 Filed May 1, 2017 16:07 UTC
Palti YoramDirector · Chief Technology Officer
SaleOrdinary Shares 4,000 $11.29 $45,160.00
Disclosure

SEC source: 0000899243-17-011267 · doc4.xml · nonDerivative · entry 2

Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,825

F2 · price: On April 28, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $10.65 to $11.60. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 27, 2017 Filed May 1, 2017 16:07 UTC
Palti YoramDirector · Chief Technology Officer
SaleOrdinary Shares 4,000 $11.21 $44,820.00
Disclosure

SEC source: 0000899243-17-011267 · doc4.xml · nonDerivative · entry 1

Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,825

F1 · price: On April 27, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $10.70 to $11.60. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 26, 2017 Filed Apr 27, 2017 16:05 UTC
Palti YoramDirector · Chief Technology Officer
SaleOrdinary Shares 4,000 $10.78 $43,100.00
Disclosure

SEC source: 0000899243-17-011007 · doc4.xml · nonDerivative · entry 2

Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,825

F2 · price: On April 26, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $10.65 to $10.95. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected

Read SEC document
April 25, 2017 Filed Apr 27, 2017 16:05 UTC
Palti YoramDirector · Chief Technology Officer
SaleOrdinary Shares 4,000 $10.79 $43,164.00
Disclosure

SEC source: 0000899243-17-011007 · doc4.xml · nonDerivative · entry 1

Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,825

F1 · price: On April 25, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $10.65 to $10.95. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 24, 2017 Filed Apr 25, 2017 16:05 UTC
Palti YoramDirector · Chief Technology Officer
SaleOrdinary Shares 4,000 $11.06 $44,244.00
Disclosure

SEC source: 0000899243-17-010851 · doc4.xml · nonDerivative · entry 2

Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,825

F2 · price: On April 24, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $10.65 to $11.60. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected

Read SEC document
April 21, 2017 Filed Apr 25, 2017 16:05 UTC
Palti YoramDirector · Chief Technology Officer
SaleOrdinary Shares 4,000 $11.45 $45,804.00
Disclosure

SEC source: 0000899243-17-010851 · doc4.xml · nonDerivative · entry 1

Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,825

F1 · price: On April 21, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $11.35 to $11.55. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 20, 2017 Filed Apr 21, 2017 16:05 UTC
Palti YoramDirector · Chief Technology Officer
SaleOrdinary Shares 4,000 $11.46 $45,820.00
Disclosure

SEC source: 0000899243-17-010709 · doc4.xml · nonDerivative · entry 2

Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 123,825

F2 · price: On April 20, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $11.15 to $11.55. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 19, 2017 Filed Apr 21, 2017 16:05 UTC
Palti YoramDirector · Chief Technology Officer
SaleOrdinary Shares 4,000 $11.03 $44,132.00
Disclosure

SEC source: 0000899243-17-010709 · doc4.xml · nonDerivative · entry 1

Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 127,825

F1 · price: On April 19, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $10.90 to $11.20. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 18, 2017 Filed Apr 19, 2017 16:09 UTC
Palti YoramDirector · Chief Technology Officer
SaleOrdinary Shares 4,000 $10.64 $42,556.00
Disclosure

SEC source: 0000899243-17-010524 · doc4.xml · nonDerivative · entry 4

Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,825

F4 · price: On April 18, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $10.475 to $10.825. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 17, 2017 Filed Apr 19, 2017 16:09 UTC
Palti YoramDirector · Chief Technology Officer
SaleOrdinary Shares 4,000 $10.77 $43,076.00
Disclosure

SEC source: 0000899243-17-010524 · doc4.xml · nonDerivative · entry 3

Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135,825

F3 · price: On April 17, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $10.55 to $11.15. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 13, 2017 Filed Apr 19, 2017 16:09 UTC
Palti YoramDirector · Chief Technology Officer
SaleOrdinary Shares 4,000 $10.43 $41,724.00
Disclosure

SEC source: 0000899243-17-010524 · doc4.xml · nonDerivative · entry 2

Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 139,825

F2 · price: On April 13, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $10.30 to $10.65. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected

Read SEC document
April 12, 2017 Filed Apr 19, 2017 16:09 UTC
Palti YoramDirector · Chief Technology Officer
SaleOrdinary Shares 4,000 $10.72 $42,864.00
Disclosure

SEC source: 0000899243-17-010524 · doc4.xml · nonDerivative · entry 1

Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,825

F1 · price: On April 12, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $10.40 to $11.05. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 14, 2017 Filed Mar 16, 2017 16:06 UTC PurchaseOrdinary Shares 125,000 $6.93 $866,250.00
Disclosure

SEC source: 0000899243-17-007750 · doc4.xml · nonDerivative · entry 1

Perlhagen Gert L. · CIK 0001654361 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,125,000

F1 · price: On March 14, 2017, Mr. Perlhagen purchased 125,000 shares in multiple trades at prices ranging from $6.825 to $7.05. The price reported above reflects the weighted average purchase price. Mr. Perlhagen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 08, 2017 Filed Mar 9, 2017 22:08 UTC
DOYLE WILLIAM FDirector · Executive Chairman · 10% owner
OtherOrdinary Shares 19,732,767 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-17-007012 · doc4.xml · nonDerivative · entry 1

DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman · 10% owner

WFD Ventures Fund II, L.P. · CIK 0001481972 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · WFD Ventures Fund II, L.P.

Disclosed balance after: 43,000

F1 · kind: On March 8, 2017, WFD Ventures Fund II, L.P. distributed, on a pro-rata basis and without consideration, to its economic partners 19,732,767 of the Issuer's shares, including 625,954 of such shares to WFD-GP II, LLC.

F1 · price: On March 8, 2017, WFD Ventures Fund II, L.P. distributed, on a pro-rata basis and without consideration, to its economic partners 19,732,767 of the Issuer's shares, including 625,954 of such shares to WFD-GP II, LLC.

F2 · ownership.nature: Mr. Doyle is a managing director of WFD Ventures LLC, the sole member of WFD-GP II, LLC, which is the general partner of WFD Ventures Fund II, L.P. Mr. Doyle disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest.

Read SEC document
March 07, 2017 Filed Mar 9, 2017 09:05 UTC OtherOrdinary Shares 6,000,000 $0.00 $0.00
Disclosure

SEC source: 0001123292-17-000594 · edgar.xml · nonDerivative · entry 1

Perlhagen Gert L. · CIK 0001654361 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000,000

F1 · kind: Distribution from the Oden Trust to Mr. Perlhagen.

Read SEC document
February 28, 2017 Filed Mar 3, 2017 00:21 UTC
DOYLE WILLIAM FDirector · Executive Chairman · 10% owner
WFD Ventures Fund II, L.P.10% owner · Director by Deputization
Exercise / conversionWarrants · Derivative 525,618 $0.00 Strike: $3.59 $0.00
Disclosure

SEC source: 0000899243-17-006165 · doc4.xml · derivative · entry 7

DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman · 10% owner

WFD Ventures Fund II, L.P. · CIK 0001481972 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · WFD Ventures Fund II, L.P.

Disclosed balance after: 0

Underlying: Ordinary Shares · 525,618 shares

Expires 2018-07-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: Currently exercisable as of the date hereof.

F1 · ownership.nature: Mr. Doyle is a managing director of WFD Ventures LLC, the sole member of WFD-GP II, LLC, which is the general partner of WFD Ventures Fund II, L.P. Mr. Doyle disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest.

Read SEC document
February 28, 2017 Filed Mar 3, 2017 00:21 UTC
DOYLE WILLIAM FDirector · Executive Chairman · 10% owner
WFD Ventures Fund II, L.P.10% owner · Director by Deputization
Exercise / conversionWarrants · Derivative 686,836 $0.00 Strike: $3.59 $0.00
Disclosure

SEC source: 0000899243-17-006165 · doc4.xml · derivative · entry 6

DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman · 10% owner

WFD Ventures Fund II, L.P. · CIK 0001481972 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · WFD Ventures Fund II, L.P.

Disclosed balance after: 0

Underlying: Ordinary Shares · 686,836 shares

Expires 2017-07-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: Currently exercisable as of the date hereof.

F1 · ownership.nature: Mr. Doyle is a managing director of WFD Ventures LLC, the sole member of WFD-GP II, LLC, which is the general partner of WFD Ventures Fund II, L.P. Mr. Doyle disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest.

Read SEC document
February 28, 2017 Filed Mar 3, 2017 00:21 UTC
DOYLE WILLIAM FDirector · Executive Chairman · 10% owner
WFD Ventures Fund II, L.P.10% owner · Director by Deputization
Tax withholdingOrdinary Shares 248,285 $7.60 $1,886,966.00
Disclosure

SEC source: 0000899243-17-006165 · doc4.xml · nonDerivative · entry 4

DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman · 10% owner

WFD Ventures Fund II, L.P. · CIK 0001481972 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · WFD Ventures Fund II, L.P.

Disclosed balance after: 19,775,767

F3 · kind: Reflects 248,285 ordinary shares withheld by the issuer at the market price of $7.60 per share less an exercise price of $3.59 per share in connection with the cashless exercise of 277,333 warrants to purchase ordinary shares owned by WFD Ventures Fund II, L.P.

F1 · ownership.nature: Mr. Doyle is a managing director of WFD Ventures LLC, the sole member of WFD-GP II, LLC, which is the general partner of WFD Ventures Fund II, L.P. Mr. Doyle disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest.

Read SEC document
February 28, 2017 Filed Mar 3, 2017 00:21 UTC
DOYLE WILLIAM FDirector · Executive Chairman · 10% owner
WFD Ventures Fund II, L.P.10% owner · Director by Deputization
Exercise / conversionOrdinary Shares 525,618 $3.59 $1,886,968.62
Disclosure

SEC source: 0000899243-17-006165 · doc4.xml · nonDerivative · entry 3

DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman · 10% owner

WFD Ventures Fund II, L.P. · CIK 0001481972 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · WFD Ventures Fund II, L.P.

Disclosed balance after: 20,024,052

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: Mr. Doyle is a managing director of WFD Ventures LLC, the sole member of WFD-GP II, LLC, which is the general partner of WFD Ventures Fund II, L.P. Mr. Doyle disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest.

Read SEC document
February 28, 2017 Filed Mar 3, 2017 00:21 UTC
DOYLE WILLIAM FDirector · Executive Chairman · 10% owner
WFD Ventures Fund II, L.P.10% owner · Director by Deputization
Tax withholdingOrdinary Shares 324,440 $7.60 $2,465,744.00
Disclosure

SEC source: 0000899243-17-006165 · doc4.xml · nonDerivative · entry 2

DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman · 10% owner

WFD Ventures Fund II, L.P. · CIK 0001481972 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · WFD Ventures Fund II, L.P.

Disclosed balance after: 19,498,434

F2 · kind: Reflects 324,440 ordinary shares withheld by the issuer at the market price of $7.60 per share less an exercise price of $3.59 per share in connection with the cashless exercise of 362,396 warrants to purchase ordinary shares owned by WFD Ventures Fund II, L.P.

F1 · ownership.nature: Mr. Doyle is a managing director of WFD Ventures LLC, the sole member of WFD-GP II, LLC, which is the general partner of WFD Ventures Fund II, L.P. Mr. Doyle disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest.

Read SEC document
February 28, 2017 Filed Mar 3, 2017 00:21 UTC
DOYLE WILLIAM FDirector · Executive Chairman · 10% owner
WFD Ventures Fund II, L.P.10% owner · Director by Deputization
Exercise / conversionOrdinary Shares 686,836 $3.59 $2,465,741.24
Disclosure

SEC source: 0000899243-17-006165 · doc4.xml · nonDerivative · entry 1

DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman · 10% owner

WFD Ventures Fund II, L.P. · CIK 0001481972 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · WFD Ventures Fund II, L.P.

Disclosed balance after: 19,822,874

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · balance_after: The Amendment filed on Form 4/A on February 21, 2017 incorrectly reflected the total number of ordinary shares beneficially owned by WFD Ventures Fund II, L.P. WFD Ventures Fund II, L.P. beneficially owned 19,136,038 ordinary shares following the transactions reported by the aforementioned Form 4/A.

F1 · ownership.nature: Mr. Doyle is a managing director of WFD Ventures LLC, the sole member of WFD-GP II, LLC, which is the general partner of WFD Ventures Fund II, L.P. Mr. Doyle disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest.

Read SEC document
February 27, 2017 Filed Feb 28, 2017 21:06 UTC
Danziger AsafDirector · Chief Executive Officer
Exercise / conversionOptions to Buy Ordinary Shares · Derivative 342,954 $0.00 Strike: $0.17 $0.00
Disclosure

SEC source: 0000899243-17-005561 · doc4.xml · derivative · entry 2

Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 342,954 shares

Expires 2017-03-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Fully vested and currently exercisable as of the date hereof.

Read SEC document
February 27, 2017 Filed Feb 28, 2017 21:06 UTC
Danziger AsafDirector · Chief Executive Officer
Exercise / conversionOrdinary Shares 342,954 $0.17 $58,302.18
Disclosure

SEC source: 0000899243-17-005561 · doc4.xml · nonDerivative · entry 1

Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,338,797

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 22, 2017 Filed Feb 24, 2017 16:06 UTC GrantRestricted Stock Unit · Derivative 65,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-17-005222 · doc4.xml · derivative · entry 2

Longsworth Todd Christopher · CIK 0001693530 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,000

Underlying: Ordinary Shares · 65,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one (1) ordinary share.

F3 · derivative.exercise_date: One-third of these restricted stock units are scheduled to vest on each of February 22, 2018, February 22, 2019, and February 22, 2020, subject to Mr. Longsworth's continued employment through such dates.

F3 · derivative.expiration_date: One-third of these restricted stock units are scheduled to vest on each of February 22, 2018, February 22, 2019, and February 22, 2020, subject to Mr. Longsworth's continued employment through such dates.

Read SEC document
February 22, 2017 Filed Feb 24, 2017 16:06 UTC GrantOptions to Buy Ordinary Shares · Derivative 227,500 $0.00 Strike: $7.15 $0.00
Disclosure

SEC source: 0000899243-17-005222 · doc4.xml · derivative · entry 1

Longsworth Todd Christopher · CIK 0001693530 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 227,500

Underlying: Ordinary Shares · 227,500 shares

Expires 2027-02-22

F1 · derivative.exercise_date: Options to buy 227,500 ordinary shares will vest and become exercisable in equal installments on each of February 22, 2018, 2019, 2020 and 2021, subject to Mr. Longsworth's continued employment through such dates.

Read SEC document
February 22, 2017 Filed Feb 24, 2017 16:09 UTC
Kirson Eilon D.Chief Scientific Officer
GrantRestricted Stock Unit · Derivative 109,200 $0.00 $0.00
Disclosure

SEC source: 0000899243-17-005227 · doc4.xml · derivative · entry 2

Kirson Eilon D. · CIK 0001654356 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,200

Underlying: Ordinary Shares · 109,200 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one (1) ordinary share.

F3 · derivative.exercise_date: One-third of these restricted stock units are scheduled to vest on each of February 22, 2018, February 22, 2019, and February 22, 2020, subject to Mr. Kirson's continued employment through such dates.

F3 · derivative.expiration_date: One-third of these restricted stock units are scheduled to vest on each of February 22, 2018, February 22, 2019, and February 22, 2020, subject to Mr. Kirson's continued employment through such dates.

Read SEC document
February 22, 2017 Filed Feb 24, 2017 16:09 UTC
Kirson Eilon D.Chief Scientific Officer
GrantOptions to Buy Ordinary Shares · Derivative 273,000 $0.00 Strike: $7.15 $0.00
Disclosure

SEC source: 0000899243-17-005227 · doc4.xml · derivative · entry 1

Kirson Eilon D. · CIK 0001654356 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 273,000

Underlying: Ordinary Shares · 273,000 shares

Expires 2027-02-22

F1 · derivative.exercise_date: Options to buy 273,000 ordinary shares will vest and become exercisable in equal installments on each of February 22, 2018, 2019, 2020 and 2021, subject to Mr. Kirson's continued employment through such dates.

Read SEC document
February 22, 2017 Filed Feb 24, 2017 16:07 UTC
Ambrogi Michael J.Chief Operating Officer
GrantRestricted Stock Unit · Derivative 93,600 $0.00 $0.00
Disclosure

SEC source: 0000899243-17-005224 · doc4.xml · derivative · entry 2

Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,600

Underlying: Ordinary Shares · 93,600 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one (1) ordinary share.

F3 · derivative.exercise_date: One-third of these restricted stock units are scheduled to vest on each of February 22, 2018, February 22, 2019, and February 22, 2020, subject to Mr. Ambrogi's continued employment through such dates.

F3 · derivative.expiration_date: One-third of these restricted stock units are scheduled to vest on each of February 22, 2018, February 22, 2019, and February 22, 2020, subject to Mr. Ambrogi's continued employment through such dates.

Read SEC document
February 22, 2017 Filed Feb 24, 2017 16:07 UTC
Ambrogi Michael J.Chief Operating Officer
GrantOptions to Buy Ordinary Shares · Derivative 234,000 $0.00 Strike: $7.15 $0.00
Disclosure

SEC source: 0000899243-17-005224 · doc4.xml · derivative · entry 1

Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 234,000

Underlying: Ordinary Shares · 234,000 shares

Expires 2027-02-22

F1 · derivative.exercise_date: Options to buy 234,000 ordinary shares will vest and become exercisable in equal installments on each of February 22, 2018, 2019, 2020 and 2021, subject to Mr. Ambrogi's continued employment through such dates.

Read SEC document
February 22, 2017 Filed Feb 24, 2017 21:05 UTC
Danziger AsafDirector · Chief Executive Officer
GrantRestricted Stock Unit · Derivative 160,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-17-005219 · doc4.xml · derivative · entry 2

Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,000

Underlying: Ordinary Shares · 160,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one (1) ordinary share.

F3 · derivative.exercise_date: One-third of these restricted stock units are scheduled to vest on each of February 22, 2018, February 22, 2019, and February 22, 2020, subject to Mr. Danziger's continued employment through such dates.

F3 · derivative.expiration_date: One-third of these restricted stock units are scheduled to vest on each of February 22, 2018, February 22, 2019, and February 22, 2020, subject to Mr. Danziger's continued employment through such dates.

Read SEC document
February 22, 2017 Filed Feb 24, 2017 21:05 UTC
Danziger AsafDirector · Chief Executive Officer
GrantOptions to Buy Ordinary Shares · Derivative 375,000 $0.00 Strike: $7.15 $0.00
Disclosure

SEC source: 0000899243-17-005219 · doc4.xml · derivative · entry 1

Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 375,000

Underlying: Ordinary Shares · 375,000 shares

Expires 2027-02-22

F1 · derivative.exercise_date: Options to buy 375,000 ordinary shares will vest and become exercisable in equal installments on each of February 22, 2018, 2019, 2020 and 2021, subject to Mr. Danziger's continued employment through such dates.

Read SEC document
February 22, 2017 Filed Feb 24, 2017 21:05 UTC
GROENHUYSEN WILHELMUS CMChief Financial Officer
GrantRestricted Stock Unit · Derivative 130,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-17-005216 · doc4.xml · derivative · entry 2

GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,000

Underlying: Ordinary Shares · 130,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one (1) ordinary share.

F3 · derivative.exercise_date: One-third of these restricted stock units are scheduled to vest on each of February 22, 2018, February 22, 2019, and February 22, 2020, subject to Mr. Groenhuysen's continued employment through such dates.

F3 · derivative.expiration_date: One-third of these restricted stock units are scheduled to vest on each of February 22, 2018, February 22, 2019, and February 22, 2020, subject to Mr. Groenhuysen's continued employment through such dates.

Read SEC document
February 22, 2017 Filed Feb 24, 2017 21:05 UTC
GROENHUYSEN WILHELMUS CMChief Financial Officer
GrantOptions to Buy Ordinary Shares · Derivative 292,500 $0.00 Strike: $7.15 $0.00
Disclosure

SEC source: 0000899243-17-005216 · doc4.xml · derivative · entry 1

GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 292,500

Underlying: Ordinary Shares · 292,500 shares

Expires 2027-02-22

F1 · derivative.exercise_date: Options to buy 292,500 ordinary shares will vest and become exercisable in equal installments on each of February 22, 2018, 2019, 2020 and 2021, subject to Mr. Groenhuysen's continued employment through such dates.

Read SEC document
January 06, 2017 Filed Jan 6, 2017 16:07 UTC
Ambrogi Michael J.Chief Operating Officer
GrantOrdinary Shares 1,108 $6.67 $7,393.68
Disclosure

SEC source: 0000899243-17-000677 · doc4.xml · nonDerivative · entry 1

Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,692

F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of August 1, 2016 through December 31, 2016. This transaction is also exempt under Rule 16b-3(c).

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on December 30, 2016.

Read SEC document
January 06, 2017 Filed Jan 6, 2017 21:05 UTC
Melnyk Peter M.Chief Commercial Officer
GrantOrdinary Shares 2,403 $6.67 $16,035.22
Disclosure

SEC source: 0000899243-17-000673 · doc4.xml · nonDerivative · entry 1

Melnyk Peter M. · CIK 0001654442 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,403

F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of August 1, 2016 through December 31, 2016. This transaction is also exempt under Rule 16b-3(c).

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on December 30, 2016.

Read SEC document
January 06, 2017 Filed Jan 6, 2017 21:05 UTC
Danziger AsafDirector · Chief Executive Officer
GrantOrdinary Shares 3,156 $6.67 $21,059.99
Disclosure

SEC source: 0000899243-17-000670 · doc4.xml · nonDerivative · entry 1

Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 995,843

F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of August 1, 2016 through December 31, 2016. This transaction is also exempt under Rule 16b-3(c).

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on December 30, 2016.

Read SEC document
January 06, 2017 Filed Jan 6, 2017 21:05 UTC
GROENHUYSEN WILHELMUS CMChief Financial Officer
GrantOrdinary Shares 3,156 $6.67 $21,059.99
Disclosure

SEC source: 0000899243-17-000668 · doc4.xml · nonDerivative · entry 1

GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 266,284

F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of August 1, 2016 through December 31, 2016. This transaction is also exempt under Rule 16b-3(c).

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on December 30, 2016.

Read SEC document
January 03, 2017 Filed Jan 4, 2017 21:01 UTC
DOYLE WILLIAM FDirector · Executive Chairman · 10% owner
OtherOrdinary Shares 2,242,664 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-17-000224 · doc4.xml · nonDerivative · entry 1

DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman · 10% owner

WFD Ventures Fund II, L.P. · CIK 0001481972 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · WFD Ventures Fund A, LLC

Disclosed balance after: 0

F1 · kind: On January 3, 2017, WFD Ventures Fund A, LLC distributed to its sole economic member all of the Issuer shares that it held in connection with its liquidation. Neither Mr. Doyle nor WFD Ventures Fund II, L.P. had any pecuniary interest in the distributed shares.

F1 · price: On January 3, 2017, WFD Ventures Fund A, LLC distributed to its sole economic member all of the Issuer shares that it held in connection with its liquidation. Neither Mr. Doyle nor WFD Ventures Fund II, L.P. had any pecuniary interest in the distributed shares.

F2 · ownership.nature: Mr. Doyle is a managing director of WFD Ventures LLC, which is the managing member of WFD Ventures Fund A, LLC. Mr. Doyle disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest.

Read SEC document
December 22, 2016 Filed Dec 22, 2016 16:59 UTC
Ambrogi Michael J.Chief Operating Officer
SaleOrdinary Shares 7,500 $8.09 $60,695.25
Disclosure

SEC source: 0000899243-16-036261 · doc4.xml · nonDerivative · entry 2

Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,584

F2 · price: On December 22, 2016, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 7,500 shares in multiple trades at prices ranging from $8.00 to $8.175. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 21, 2016 Filed Dec 22, 2016 16:59 UTC
Ambrogi Michael J.Chief Operating Officer
SaleOrdinary Shares 20,000 $8.33 $166,608.00
Disclosure

SEC source: 0000899243-16-036261 · doc4.xml · nonDerivative · entry 1

Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 139,084

F1 · price: On December 21, 2016, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 20,000 shares in multiple trades at prices ranging from $8.075 to $8.65. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 20, 2016 Filed Dec 21, 2016 16:50 UTC
Ambrogi Michael J.Chief Operating Officer
SaleOrdinary Shares 20,000 $8.62 $172,476.00
Disclosure

SEC source: 0000899243-16-036180 · doc4.xml · nonDerivative · entry 2

Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 159,084

F2 · price: On December 20, 2016, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 20,000 shares in multiple trades at prices ranging from $8.525 to $8.80. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 19, 2016 Filed Dec 21, 2016 16:50 UTC
Ambrogi Michael J.Chief Operating Officer
SaleOrdinary Shares 20,000 $8.76 $175,178.00
Disclosure

SEC source: 0000899243-16-036180 · doc4.xml · nonDerivative · entry 1

Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 179,084

F1 · price: On December 19, 2016, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 20,000 shares in multiple trades at prices ranging from $8.55 to $9.05. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 16, 2016 Filed Dec 19, 2016 16:05 UTC
Ambrogi Michael J.Chief Operating Officer
SaleOrdinary Shares 20,000 $8.71 $174,270.00
Disclosure

SEC source: 0000899243-16-035928 · doc4.xml · nonDerivative · entry 2

Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 199,084

F2 · price: On December 16, 2016, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 20,000 shares in multiple trades at prices ranging from $8.425 to $9.15. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected

Read SEC document
December 15, 2016 Filed Dec 19, 2016 16:05 UTC
Ambrogi Michael J.Chief Operating Officer
SaleOrdinary Shares 20,000 $9.14 $182,858.00
Disclosure

SEC source: 0000899243-16-035928 · doc4.xml · nonDerivative · entry 1

Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 219,084

F1 · price: On December 15, 2016, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 20,000 shares in multiple trades at prices ranging from $9.00 to $9.375. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 14, 2016 Filed Dec 15, 2016 16:05 UTC
Ambrogi Michael J.Chief Operating Officer
SaleOrdinary Shares 20,000 $8.96 $179,294.00
Disclosure

SEC source: 0000899243-16-035594 · doc4.xml · nonDerivative · entry 2

Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 239,084

F2 · price: On December 14, 2016, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 20,000 shares in multiple trades at prices ranging from $8.65 to $9.15. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 13, 2016 Filed Dec 15, 2016 16:05 UTC
Ambrogi Michael J.Chief Operating Officer
SaleOrdinary Shares 20,000 $8.98 $179,688.00
Disclosure

SEC source: 0000899243-16-035594 · doc4.xml · nonDerivative · entry 1

Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 259,084

F1 · price: On December 13, 2016, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 20,000 shares in multiple trades at prices ranging from $8.65 to $9.40. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 12, 2016 Filed Dec 13, 2016 16:06 UTC
Ambrogi Michael J.Chief Operating Officer
SaleOrdinary Shares 10,000 $9.04 $90,442.00
Disclosure

SEC source: 0000899243-16-035397 · doc4.xml · nonDerivative · entry 2

Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 279,084

F2 · price: On December 12, 2016, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 10,000 shares in multiple trades at prices ranging from $8.80 to $9.40. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 09, 2016 Filed Dec 13, 2016 16:06 UTC
Ambrogi Michael J.Chief Operating Officer
SaleOrdinary Shares 5,000 $8.93 $44,668.00
Disclosure

SEC source: 0000899243-16-035397 · doc4.xml · nonDerivative · entry 1

Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 289,084

F1 · price: On December 9, 2016, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 5,000 shares in multiple trades at prices ranging from $8.70 to $9.20. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 08, 2016 Filed Dec 9, 2016 16:05 UTC
Ambrogi Michael J.Chief Operating Officer
SaleOrdinary Shares 5,000 $8.37 $41,831.50
Disclosure

SEC source: 0000899243-16-035218 · doc4.xml · nonDerivative · entry 2

Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 294,084

F2 · price: On December 8, 2016, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 5,000 shares in multiple trades at prices ranging from $7.975 to $8.75. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.